Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diet, Metabolism, and Disease, and Hepatitis C virus research.
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of <scp>MASLD</scp>
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Spleen Stiffness–Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease
A turning point in hepatology? EASL reflects on the first approved drug for MASH
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
A global research priority agenda to advance public health responses to fatty liver disease
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
A global action agenda for turning the tide on fatty liver disease
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study
Implementation of a liver health check in people with type 2 diabetes
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
A multistakeholder approach to innovations in NAFLD care
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Non-invasive tests for clinically significant portal hypertension after HCV cure
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Baveno VII – Renewing consensus in portal hypertension
Advancing the global public health agenda for NAFLD: a consensus statement